Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events
暂无分享,去创建一个
A. Tefferi | W. Hogan | S. Hashmi | M. Elliott | K. Begna | J. Foran | A. Al-Kali | M. Kharfan-Dabaja | N. Gangat | K. Reichard | D. Viswanatha | M. Litzow | H. Alkhateeb | H. Murthy | T. Badar | C. Rivera | Maymona G Abdelmagid | Farah Fleti | Omer S Karrar | Mirinal S Patnaik | Mohammed H Elnayir